comparemela.com

Latest Breaking News On - Patient selection - Page 1 : comparemela.com

Accenture Backs Turbine s AI-Powered Platform to Accelerate Drug Discovery

Accenture Ventures makes a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development.

Should knowAccenture venturesDrug discoverySimulated cellHidden gemsMore effectivePromising drug targetsPatient selectionEffective combination therapies

iTWire - Why clinical trial patient recruitment software matters

GUEST OPINION: In the evolving realm of healthcare, technological advancements are profoundly impacting facets of clinical research. A notable domain.

Enhancing recruitment efficiencyPatient selectionOperational effectivenessBoost patient engagementPatient onboardingTrial successData managementData storageData analysisTechnology newsEch newsEchnology trendsEchnology jobsEch jobsIgital newsIgital jobs

Simple hysterectomy not inferior for pelvic recurrence in cervical cancer

Simple hysterectomy not inferior for pelvic recurrence in cervical cancer
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Pedrot ramirezMarie planteCentre hospitalier universitaire de quNew england journalRadical hysterectomyLow risk cervical cancerLess is morePatient selection

Elacestrant: Adverse Effects and Their Management, and Impact of Treatment on Quality of Life

Experts discuss the impact of elacestrant on patient well-being, including potential cardiovascular and gastrointestinal toxicities, quality of life, and patient feedback regarding access to treatment.

William gradisharGregory vidalRena callahanMabel mardonesPeer exchangeEuropean society for medical oncology congressMedical oncology congressOral serdMetastatic breast cancerTherapeutic advancesPanel discussionHer positiveHer2 negativeSelective estrogen receptor degraderEndocrine therapyTargeted therapy

Elacestrant: Treatment Considerations, Including Dosing and Compliance

Experts explore treatment considerations when treating patients with metastatic breast cancer with elacestrant, including dosing, patient selection, adherence, and treatment duration. Participants also discuss dose modifications, adherence concerns, and how they determine treatment failure.

William gradisharMabel mardonesRena callahanGregory vidalPeer exchangeOral serdMetastatic breast cancerTherapeutic advancesPanel discussionHer positiveHer2 negativeSelective estrogen receptor degraderEndocrine therapyTargeted therapyTreatment developmentsMedical oncology

vimarsana © 2020. All Rights Reserved.